Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 90 citing Alvarsson: Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic.... (0.08 sec) 

[PDF] Lower within-subject variability of fasting blood glucose and reduced weight gain …


T Haak, A Tiengo, E Draeger, M Suntum, W … - Diabetes Obesity and …, 2005 - fe-inzichten.nl
Aim: The aim of this study was to compare the efficacy and safety of a basal-bolus insulin regimen
comprising either insulin detemir or neural protamine hagedorn (NPH) insulin in combination
with mealtime insulin aspart in patients with type 2 diabetes. Methods: This was a ...
Cited by 193 - Related articles - View as HTML - All 5 versions

Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic …


MY Donath, PA Halban - Diabetologia, 2004 - Springer
Increasing evidence indicates that decreased functional beta-cell mass is the hallmark of both
Type 1 and Type 2 diabetes. This underlies the absolute or relative insu- lin insufficiency in both
conditions. In this For Debate, we consider the possible mechanisms responsible for beta- ...
Cited by 123 - Related articles - BL Direct - All 6 versions

{beta}-Cell Failure in Diabetes and Preservation by Clinical Treatment

- endojournals.org
BL Wajchenberg - Endocrine reviews, 2007 - Endocrine Soc
There is a progressive deterioration in ß-cell function and mass in type 2 diabetics. It was found
that islet function was about 50% of normal at the time of diagnosis, and a reduction in ß-cell
mass of about 60% was shown at necropsy. The reduction of ß-cell mass is attributable to ...
Cited by 105 - Related articles - BL Direct - All 7 versions

Mechanisms of β-cell death in type 2 diabetes


MY Donath, JA Ehses, K Maedler, DM Schumann, H … - Diabetes, 2005 - Am Diabetes Assoc
A decrease in the number of functional insulin-producing β-cells contributes to the pathophysiology
of type 2 diabetes. Opinions diverge regarding the relative contribution of a decrease in β-cell
mass versus an intrinsic defect in the secretory machinery. Here we review the evidence ...
Cited by 86 - Related articles - BL Direct - All 6 versions

Sulfonylurea Induced {beta}-Cell Apoptosis in Cultured Human Islets

- endojournals.org
K Maedler, RD Carr, D Bosco, RA Zuellig, T … - Journal of Clinical …, 2005 - Endocrine Soc
Loss of ß-cell mass and function raises a concern regarding the application of sulfonylureas
for the treatment of type 2 diabetes because previous studies have shown that agents that cause
closure of inwardly rectifying K + sulfonylurea receptor subtype of ATP-sensitive ...
Cited by 79 - Related articles - All 6 versions

Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type …


T Nakamura, T Matsuda, Y Kawagoe, H Ogawa, Y … - Metabolism, 2004 - Elsevier
Atherosclerosis is the major cause of morbidity and mortality in patients with type 2 diabetes,
and pioglitazone has been reported to have anti-inflammatory and potential antiatherogenic
effects. The aim of the present study was to determine whether pioglitazone, ...
Cited by 75 - Related articles - All 8 versions

Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet …


RA DeFronzo, RM Bergenstal, WT Cefalu, J Pullman, S … - Diabetes Care, 2005 - cat.inist.fr
OBJECTIVE- Effective type 2 diabetes management requires prompt intervention if glycemic
control is not achieved by nonpharmacological means. This study investigates whether inhaled
insulin(INH; Exubera) can achieve target glycemic control in patients failing on diet and ...
Cited by 73 - Related articles - BL Direct - All 5 versions

Does the glucose-dependent insulin secretion mechanism itself cause oxidative …


LE Fridlyand, LH Philipson - Diabetes, 2004 - Am Diabetes Assoc
Glucose-dependent insulin secretion (GDIS), reactive oxygen species (ROS) production, and
oxidative stress in pancreatic β-cells may be tightly linked processes. Here we suggest that the
same pathways used in the activation of GDIS (increased glycolytic flux, ATP-to-ADP ...
Cited by 54 - Related articles - BL Direct - All 5 versions

Effect of intensive insulin therapy on β-cell function and glycaemic control in …

- dminsulinpump.co.kr [PDF] 
J Weng, Y Li, W Xu, L Shi, Q Zhang, D Zhu, Y Hu, Z … - The Lancet, 2008 - Elsevier
382 patients, aged 25–70 years, were enrolled from nine centres in China between
September, 2004, and October, 2006. The patients, with fasting plasma glucose of 7·0–16·7
mmol/L, were randomly assigned to therapy with insulin (CSII or MDI) or oral ...
Cited by 52 - Related articles - All 25 versions

Latent Autoimmune Diabetes in Adults


G Stenström, A Gottsäter, E Bakhtadze, B Berger, G … - Diabetes, 2005 - Am Diabetes Assoc
Latent autoimmune diabetes in adults (LADA) is a disorder in which, despite the presence of
islet antibodies at diagnosis of diabetes, the progression of autoimmune β-cell failure is
slow. LADA patients are therefore not insulin requiring, at least during the first 6 months ...
Cited by 35 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google